A survey of the doses of methotrexate and salazosulfapyridine in Japanese patients with rheumatoid arthritis
Kawai, S.; Ochi, T.; Kondo, H.; Nishioka, K.; Nobuyuki, N.; Yoshino, S.
Ryumachi 42(1): 76-79
2002
ISSN/ISBN: 0300-9157 PMID: 11925910 Document Number: 540875
Document emailed within 1 workday
Related Documents
Lafforgue, P.; Monjanel-Mouterde, S.; Durand, A.; Catalin, J.; Acquaviva, P.C. 1993: Is there an interaction between low doses of corticosteroids and methotrexate in patients with rheumatoid arthritis? a pharmacokinetic study in 33 patients Journal of Rheumatology 20(2): 263-267Aaltonen, K.J.; Turunen, J.H.; Sokka, T.; Puolakka, K.; Valleala, H. 2016: A survey on the medication adherence to methotrexate among rheumatoid arthritis patients treated with self-administered biologic drugs Clinical and Experimental Rheumatology 34(4): 694-697
Halla, J.T.; Hardin, J.G. 1994: Underrecognized postdosing reactions to methotrexate in patients with rheumatoid arthritis Journal of Rheumatology 21(7): 1224-1226
Kremer, J.M. 1999: Methotrexate and radiographic disease progression in patients with rheumatoid arthritis Journal of Rheumatology 26(2): 241-243
Idolazzi, L.; Adami, S.; Capozza, R.; Bianchi, G.; Cozzolongo, A.; Epis, O.; Fusaro, E.; Lapadula, G.; Migliore, A.; Pellerito, R.; Pucino, A.; Sinigaglia, L.; Visalli, E.; Rossini, M. 2015: Suboptimal methotrexate use in rheumatoid arthritis patients in Italy: the MARi study Clinical and Experimental Rheumatology 33(6): 895-899
Phillips, C.A.; Cera, P.J.; Mangan, T.F.; Newman, E.D. 1992: Clinical liver disease in patients with rheumatoid arthritis taking methotrexate Journal of Rheumatology 19(2): 229-233
El Miedany, Y.M.; Abubakr, I.H.; El Baddini, M. 1998: Effect of low dose methotrexate on markers of bone metabolism in patients with rheumatoid arthritis Journal of Rheumatology 25(11): 2083-2087
Manorot, M.; Rojanasathien, N.; Louthrenoo, W.; Tonsuwannont, W.; Teekachunhatean, S. 1998: Comparative studies of quality and bioavailability of methotrexate in Thai patients with rheumatoid arthritis Journal of the Medical Association of Thailand 81(12): 978-985
Doita, M.; Hirohata, K.; Maeda, S. 1990: Association of HLA-DR antigens with disease severity in Japanese patients with rheumatoid arthritis Kobe Journal of Medical Sciences 36(3-4): 103-114
Golden, M.R.; Katz, R.S.; Balk, R.A.; Golden, H.E. 1995: The relationship of preexisting lung disease to the development of methotrexate pneumonitis in patients with rheumatoid arthritis Journal of Rheumatology 22(6): 1043-1047
Furst, D.E.; Erikson, N.; Clute, L.; Koehnke, R.; Burmeister, L.F.; Kohler, J.A. 1990: Adverse experience with methotrexate during 176 weeks of a longterm prospective trial in patients with rheumatoid arthritis Journal of Rheumatology 17(12): 1628-1635
Shinozawa, T.; Kameda, H.; Hama, N.; Yoshida, T.; Ohosone, Y.; Ichikawa, Y. 1998: The efficacy of combination therapy with prednisolone (PSL) and methotrexate (MTX) on radiographic progression in patients with rheumatoid arthritis (RA) Ryumachi 38(1): 14-22
Michaels, R.M.; Reading, J.C.; Beezhold, D.H.; Ward, J.R. 1996: Serum phospholipase A2 activity in patients with rheumatoid arthritis before and after treatment with methotrexate, auranofin, or combination of the two Journal of Rheumatology 23(2): 226-229
Giusti, A.; Epis, O.M.; Migliore, A.; Ricioppo, A.; Sainaghi, P.P.; Di Matteo, L.; Massarotti, M.S.; Govoni, M.; Mazzone, A.; Traballi, G.; Ciarla, S.; Cozzi, L.; Roncaglione, A.; Muratore, M.; Laurenti, R.; Bianchi, G. 2019: The effect of gender on methotrexate prescription attitudes in Italian rheumatoid arthritis patients: the MARi study Clinical and Experimental Rheumatology 37(6): 1003-1009
Boiardi, L.; Macchioni, P.; Meliconi, R.; Pulsatelli, L.; Facchini, A.; Salvarani, C. 1999: Relationship between serum RANTES levels and radiological progression in rheumatoid arthritis patients treated with methotrexate Clinical and Experimental Rheumatology 17(4): 419-425
Darabi, K.; Jaiswal, R.; Hostetler, S.; Bechtel, M.; Zirwas, M. 2009: Infectious complications in patients with psoriasis and rheumatoid arthritis treated with antitumor necrosis factor agents and methotrexate Journal of Drugs in Dermatology: Jdd 8(2): 175-178
Michaels, R.M.; Chang, Z.L.; Beezhold, D.H. 1994: Phospholipase A2 activity in peripheral blood cells of rheumatoid arthritis patients treated with methotrexate: a preliminary study Clinical and Experimental Rheumatology 12(6): 643-647
Sreekumar, R.; Gray, J.; Kay, P.; Grennan, D.M. 2011: Methotrexate and post operative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery--a ten year follow-up Acta Orthopaedica Belgica 77(6): 823-826
Ferraccioli, G.; Casatta, L.; Bartoli, E. 1996: Increase of bone mineral density and anabolic variables in patients with rheumatoid arthritis resistant to methotrexate after cyclosporin A therapy Journal of Rheumatology 23(9): 1539-1542
Detert, J.; Dziurla, R.é; Hoff, P.; Gaber, T.; Klaus, P.; Bastian, H.; Braun, T.; Schellmann, S.; Penzel, T.; Fietze, I.; Loeschmann, P.-A.; Jaehnig, P.; Straub, R.H.; Burmester, G.R.; Buttgereit, F. 2016: Effects of treatment with etanercept versus methotrexate on sleep quality, fatigue and selected immune parameters in patients with active rheumatoid arthritis Clinical and Experimental Rheumatology 34(5): 848-856